Education
About Us
Working with TipRanks
Follow Us
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
SNOA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.75 - $9.38
Previous CloseN/A
Volume16.09K
Average Volume (3M)43.53K
Market Cap
$4.71M
Enterprise Value-$354.25K
Total Cash (Recent Filing)$5.37M
Total Debt (Recent Filing)$305.00K
Price to Earnings (P/E)―
Beta2.50
Next Earnings
Aug 07, 2025EPS Estimate
-0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding1,642,765
10 Day Avg. Volume29,096
30 Day Avg. Volume43,532
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.81
Price to Sales (P/S)0.00
P/FCF Ratio-28.06
Enterprise Value/Market Cap-0.08
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit-0.09
Enterprise Value/Ebitda0.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sonoma Pharmaceuticals News
PremiumMarket News
3 Penny Stocks to Watch Now, 4/24/25
PremiumMarket News
3 Penny Stocks to Watch Now, 3/11/25
PremiumCompany Announcements
Sonoma Pharmaceuticals Ends EMC Pharma Agreement
Options Prices
Currently, No data available
---
Ownership Overview
31.44% Insiders
0.58% Mutual Funds
<0.01% Other Institutional Investors
67.57% Public Companies and Individual Investors
SNOA FAQ
What was Sonoma Pharmaceuticals’s price range in the past 12 months?
Sonoma Pharmaceuticals lowest stock price was $1.75 and its highest was $9.38 in the past 12 months.
What is Sonoma Pharmaceuticals’s market cap?
Sonoma Pharmaceuticals’s market cap is $4.71M.
When is Sonoma Pharmaceuticals’s upcoming earnings report date?
Sonoma Pharmaceuticals’s upcoming earnings report date is Aug 07, 2025 which is in 39 days.
How were Sonoma Pharmaceuticals’s earnings last quarter?
Sonoma Pharmaceuticals released its earnings results on Jun 17, 2025. The company reported -$0.152 earnings per share for the quarter, beating the consensus estimate of -$0.73 by $0.578.
Is Sonoma Pharmaceuticals overvalued?
According to Wall Street analysts Sonoma Pharmaceuticals’s price is currently Overvalued.
Does Sonoma Pharmaceuticals pay dividends?
Sonoma Pharmaceuticals does not currently pay dividends.
What is Sonoma Pharmaceuticals’s EPS estimate?
Sonoma Pharmaceuticals’s EPS estimate is -0.51.
How many shares outstanding does Sonoma Pharmaceuticals have?
Sonoma Pharmaceuticals has 1,642,765 shares outstanding.
What happened to Sonoma Pharmaceuticals’s price movement after its last earnings report?
Sonoma Pharmaceuticals reported an EPS of -$0.152 in its last earnings report, beating expectations of -$0.73. Following the earnings report the stock price went down -3.39%.
Which hedge fund is a major shareholder of Sonoma Pharmaceuticals?
Currently, no hedge funds are holding shares in SNOA
Company Description
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc. (SNOA) is a healthcare company operating primarily in the pharmaceutical and medical device sectors. The company's core focus is on developing, manufacturing, and commercializing products for the treatment of dermatological conditions and advanced tissue care. Sonoma Pharmaceuticals specializes in hypochlorous acid-based solutions which are used for wound care, eye care, oral care, and dermatology applications.
Technical Analysis
NovaBay Pharma
―
Sonnet BioTherapeutics Holdings
―
CNS Pharmaceuticals
―
FOXO Technologies
―